Search for: "Actavis"
Results 841 - 860
of 1,010
Sort by Relevance
|
Sort by Date
7 Jul 2010, 5:14 am
(Patent Docs) (Holman's Biotech IP Blog) US: AMP v USPTO after Bilski v Kappos (Patent Docs) US: NORD Chair/HP&M Director presents opening testimony at first ever FDA orphan drug hearing (FDA Law Blog) US: Celsis files patent infringement complaint against CellzDirect and Invitrogen over pooled multi-cryopreserved hepatocyte products (Patent Docs) Products Astelin (Azelastine) – US: Zydus admits infringing Meda’s Astelin patent, agrees not to market generic (Patent Docs)… [read post]
6 Jul 2010, 9:59 pm
Click here for further details.The decision of the Court of Appeal for England and Wales in Actavis UK Limited v Novartis AG -- which has the distinction of being the most-commented-upon ruling ever to have been posted on this weblog -- was bound to be the subject of an appeal. [read post]
6 Jul 2010, 6:03 pm
(Patent Docs) (Holman’s Biotech IP Blog) US: AMP v USPTO after Bilski v Kappos (Patent Docs) US: NORD Chair/HP&M Director presents opening testimony at first ever FDA orphan drug hearing (FDA Law Blog) US: Celsis files patent infringement complaint against CellzDirect and Invitrogen over pooled multi-cryopreserved hepatocyte products (Patent Docs) Products Astelin (Azelastine) – US: Zydus admits infringing Meda’s Astelin patent, agrees not to market generic (Patent Docs)… [read post]
10 Jun 2010, 3:58 am
Actavis Inc. et al. [read post]
7 Jun 2010, 5:06 am
The recent Court of Appeal decision in Actavis v Merck [2008] RPC 26 [noted by the IPKat here] reaffirmed the desirability of maintaining conformity with EPO practice as established in Board of Appeal decisions in this field, and so Swiss-type claims to second medical uses will no longer be allowed.Effect of this change - pre-grant applications7. [read post]
2 Jun 2010, 3:02 pm
Finnicum's suit against Actavis-Elizabeth may proceed as planned, but the drug's original development/manufacturing companies, Wyeth and Schwarz Pharma, are excluded. [read post]
30 May 2010, 3:55 pm
Mensing/Actavis Elizabeth v. [read post]
27 May 2010, 3:20 am
Actavis Elizabeth LLC et al. [read post]
26 May 2010, 3:01 pm
It follows that before the Boards of appeal the parties may expect to dispose of intact rights as to the organisation of their defence.Any infringement of this principle would not only affect the integrity of the rights of the parties but would also be incompatible with the principle of independence of the members of the Board of appeal asserted in A 23(3), which members shall comply only with the provisions of this Convention and shall not be bound by any instructions.[2.4] However, this principle… [read post]
25 May 2010, 12:51 pm
Actavis. [read post]
24 May 2010, 7:46 am
Mensing; Actavis Elizabeth v. [read post]
24 May 2010, 7:42 am
Mensing (09-993) and Actavis Elizabeth v. [read post]
13 May 2010, 4:58 pm
Pharma Change ApS - Actavis A/S entered as independent party (EPLAW) Metvixia (Methyl aminolevulinate) - US: CAFC upholds patent term extensions in Levaquin and Metvixia cases: Ortho-McNeil and Daiichi Sankyo v. [read post]
11 May 2010, 9:06 pm
Generic manufacturers of metoclopramide including Teva Pharmaceuticals and Actavis Elizabeth. [read post]
6 May 2010, 9:43 am
The Food, Drug, and Cosmetic Act (“FDCA”) was enacted in 1938 to regulate, among other things, the drug and medical device industry in order to ensure the safe and effective design, manufacture, sale and labeling of such products. [read post]
1 May 2010, 9:45 am
Generic manufacturers of metoclopramide including Teva Pharmaceuticals and Actavis Elizabeth. [read post]
23 Mar 2010, 4:00 pm
While Actavis has not admitted any wrongdoing, the lawsuit alleged that Actavis reported inflated prices to drug industry reporting services. [read post]
18 Mar 2010, 2:15 am
Teva Pharmaceutical Industries has won the bidding contest for German generic drug maker Ratiopharm, beating out Pfizer and Actavis, three people close to the matter told Reuters. [read post]
15 Mar 2010, 6:03 pm
Actavis, Inc., 2010 WL 46513 (C.A. 5 (La.). [read post]
24 Feb 2010, 2:11 am
(Patent Docs) US: PhRMA representative questions follow-on biologics paper (Patent Docs) USPTO announces agenda for next biotechnology/chemical/pharmaceutical customer partnership meeting (Patent Docs) Products Arzerra (Ofatumumab) – US: Glaxo Group, GlaxoSmithKline seek declaratory judgment of invalidity and non-infringement against Genentech, City of Hope (Patent Docs) Cipro (Ciprofloxacin) – US: Bayer files patent infringement complaints against Lupin in Maryland and Delaware… [read post]
